Expert Point of View: Theodore DeWeese, MD

Get Permission

Theodore DeWeese, MD

The goal of therapy is to maximize cure. Limiting radiation therapy and other types of cancer therapies is reasonable to minimize side effects, but at times this path might lead to increased risk of cancer recurrence,” said Theodore DeWeese, MD, Chairman of the Department of Radiation Oncology and Molecular Radiation Science at the James Buchanan Brady Urology Institute at Johns Hopkins University School of Medicine in Baltimore.

“Dr. Parikh’s study shows that to maximize cure, early-stage Hodgkin lymphoma patients need radiation and chemotherapy. We always seek to maximize cure and minimize side effects. The belief that radiation has long-term consequences leads to omission of radiation therapy, perhaps inappropriately. Dr. Parikh has shown that perhaps these fears may lead some to inappropriately exclude radiation from the treatment plan,” Dr. DeWeese stated. ■

Disclosure: Dr. DeWeese reported no potential conflicts of interest.


Related Articles

Radiation Therapy Improves 10-Year Survival for Patients With Early Hodgkin Lymphoma, but Frequently Omitted in Treatment Plans

Adding consolidation radiation therapy to chemotherapy significantly improves 10-year survival in patients with stage I and II Hodgkin lymphoma, according to a large observational study based on the National Cancer Database (NCDB). Yet over that same 10-year period, radiation therapy use declined...




By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.